What This Bill Does · Plain English
Summary · Congress.gov
Women and Lung Cancer Research and Preventive Services Act of 2025 This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public education campaign.
Action Timeline
2026-04-22
Received in the Senate. Read twice. Placed on Senate Legislative Calendar under General Orders. Calendar No. 380.
2026-04-21
Motion to reconsider laid on the table Agreed to without objection.
2026-04-21
On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
2026-04-21
Passed/agreed to in House: On motion to suspend the rules and pass the bill Agreed to by voice vote. (text: CR H3020)
2026-04-21
DEBATE - The House proceeded with forty minutes of debate on H.R. 2319.
2026-04-21
Considered under suspension of the rules. (consideration: CR H3020-3021)
2026-04-21
Mrs. Harshbarger moved to suspend the rules and pass the bill.
2025-11-18
Placed on the Union Calendar, Calendar No. 332.
2025-11-18
Reported by the Committee on Energy and Commerce. H. Rept. 119-382.
2025-11-18
Reported by the Committee on Energy and Commerce. H. Rept. 119-382.
Frequently Asked Questions
Did HR.2319 pass?
HR.2319 is still alive. Current stage: PASSED_ONE. Pass likelihood: 40%.
What does HR.2319 do?
Women and Lung Cancer Research and Preventive Services Act of 2025 This bill requires the Department of Health and Human Services to conduct an interagency review to accelerate lung cancer research, prevention, and awareness with respect to women and underserved populations. The review must report on the status of existing research and current knowledge gaps; identify new opportunities for collaborative research to determine the causes of lung cancer and advance prevention, screening, diagnosis, and treatment; and provide recommendations for a national lung cancer screening strategy and public…
Who sponsored HR.2319?
HR.2319 was sponsored by Brendan F. Boyle (D-Pennsylvania).
Full Bill Text
119 HR 2319 EH: Women and Lung Cancer Research and Preventive Services Act of 2025 U.S. House of Representatives text/xml EN Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain. IB 119th CONGRESS 2d Session H. R. 2319 IN THE HOUSE OF REPRESENTATIVES AN ACT To direct the Secretary of Health and Human Services to conduct a review to evaluate the status of research on lung cancer in women and underserved populations, and for other purposes. 1. Short title This Act may be cited as the Women and Lung Cancer Research and Preventive Services Act of 2025 . 2. Interagency review to evaluate and identify opportunities for the acceleration of research on lung cancer in women and underserved populations, greater access to preventive services, and strategic public awareness and education campaigns (a) In general The Secretary of Health and Human Services, in consultation with the Secretary of Defense and the Secretary of Veterans Affairs, shall conduct an interagency review to evaluate the status of, and identify opportunities for the acceleration of research related to— (1) research on lung cancer in women; (2) research on lung cancer in underserved populations that meet the eligibility criteria for lung cancer screening as recommended by the United States Preventive Services Task Force; (3) access to lung cancer preventive services; and (4) strategic public awareness and education campaigns on lung cancer. (b) Content The review and recommendations under subsection (a) shall include— (1) a review and comprehensive report on the outcomes of previous research, the status of existing research activities, and knowledge gaps related to lung cancer in women and underserved populations in all agencies of the Federal Government; (2) opportunities for collaborative, interagency, multidisciplinary, and innovative research, that would— (A) encourage innovative approaches to eliminate knowledge gaps in research on lung cancer in women; (B) evaluate environmental and genomic factors that may be related to the etiology of lung cancer in women; and (C) foster advances in imaging technology and techniques to improve risk assessment, diagnosis, treatment, and the simultaneous utilization of other preventive services and activities; (3) opportunities regarding the development of a national lung cancer screening strategy to expand access to such screenings, particularly among women and underserved populations; and (4) opportunities regarding the development of a national public education and awareness campaign on— (A) lung cancer in women and underserved populations; and (B) the importance of early detection of lung cancer. (c) Report Not later than two years after the date of the enactment of this Act, the Secretary of Health and Human Services shall submit to Congress a report on the review conducted under subsection (a). Passed the House of Representatives April 21, 2026. Kevin F. McCumber, Clerk.
Loading intelligence layer…